Pfizer is 'deeply sorry'
Dr. John Campbell・10 minutes read
Fiser was found guilty of multiple breaches of the 2019 code, including promoting an unlicensed medicine and making misleading claims. The company's senior executives violated the regulatory code by promoting an unlicensed COVID vaccine on social media.
Insights
- Fiser's misconduct involved breaching multiple clauses of the 2019 code, such as bringing discredit to the pharmaceutical industry and promoting an unlicensed medicine, leading to a lack of high standards maintenance.
- The senior executives of Fiser used social media to promote an unlicensed COVID vaccine, violating the regulatory code multiple times, including failing to provide safety information about the vaccine candidate, despite acknowledging the breaches and attempting to address them through social media training.
Get key ideas from YouTube videos. It’s free
Recent questions
What breaches did Fiser commit?
Fiser breached Clauses 2, 3.1, 7.2, and 9.1.
Related videos
The BMJ
Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial
The Deshbhakt
Patanjali Vs Supreme Court | How Baba Ramdev Grew Powerful Enough to Mock The Law | Akash Banerjee
Lab Muffin Beauty Science
Impressively Bad Skincare Science: Matter of Fact
FRONTLINE PBS | Official
Opioids, Inc. (full documentary) | FRONTLINE
LastWeekTonight
Cryptocurrencies II: Last Week Tonight with John Oliver (HBO)
Summary
00:00
Fiser's Misconduct: Breaches in Pharmaceutical Industry
- A report on Fiser's misconduct was discussed, highlighting breaches of various clauses in the 2019 code.
- Fiser was found to have breached Clause 2, bringing discredit to the pharmaceutical industry, and Clause 3.1, promoting an unlicensed medicine.
- The company also breached Clause 7.2 by making misleading claims and Clause 9.1 by failing to maintain high standards.
- Fiser's senior executives used social media to promote an unlicensed COVID vaccine, breaching the regulatory code five times.
- The Prescription Medicines Code of Practice Authority ruled on a complaint about a message posted on Twitter by Fiser employees.
- The panel noted that the Tweet lacked safety information regarding the vaccine candidate, breaching Clause 3.1.
- Fiser acknowledged the breaches and stated that the senior employee involved had completed social media training but failed to take down the post.
